|
Mangoceuticals Inc (NASDAQ: MGRX) |
|
Mangoceuticals Inc
MGRX's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Mangoceuticals Inc growth rates, revenue grew
by 15.52 % in II. Quarter 2024 from the same quarter a year ago.
Ranking at No. 790
Healthcare Facilities industry recorded
growth of revenues by 8.64 %
Mangoceuticals Inc net loss increased from $-2 millions, to $-2 millions in II. Quarter 2024,
• More on MGRX's Growth
|
|
Mangoceuticals Inc realized a net loss in trailing twelve months.
Mangoceuticals Inc realized cash reduction of $ -0.09 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 76.78.
Healthcare Facilities industry's Price to Sales ratio is at 1.1.
• More on MGRX's Valuation
|
|
|
|
|
Mangoceuticals Inc realized net loss in trailing twelve months.
Mangoceuticals Inc realized cash outflow of $ -0.09per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 76.78.
Healthcare Facilities industry's Price to Sales ratio is at 1.1.
Mangoceuticals Inc Price to Book Ratio is at 4.81 lower than Industry Avg. of 204.13. and higher than S&P 500 Avg. of 0.01
• More on MGRX's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com